gptkbp:instanceOf
|
gptkb:chemical_compound
gptkb:nitrosourea
antineoplastic agent
|
gptkbp:approvalYear
|
1977
|
gptkbp:approvedBy
|
gptkb:FDA
|
gptkbp:aroma
|
none
|
gptkbp:ATCCode
|
L01AD01
|
gptkbp:brand
|
gptkb:BiCNU
gptkb:Gliadel
|
gptkbp:CASNumber
|
154-93-8
|
gptkbp:color
|
yellow
|
gptkbp:discoveredBy
|
gptkb:National_Cancer_Institute
|
gptkbp:drugClass
|
antineoplastic agent
|
gptkbp:eliminationHalfLife
|
15-30 minutes
|
gptkbp:excretion
|
gptkb:kidney
|
gptkbp:hasInChIKey
|
XQNWGFRJXWCOJM-UHFFFAOYSA-N
|
gptkbp:hasMolecularFormula
|
C5H9Cl2N3O2
|
gptkbp:hasSMILES
|
C(CN(CCCl)C(=O)N(CCCl)N=O)Cl
|
gptkbp:hasStorageRequirement
|
refrigerated
|
gptkbp:hasUNII
|
U68V09E7SZ
|
https://www.w3.org/2000/01/rdf-schema#label
|
Carmustine
|
gptkbp:isSolubleIn
|
gptkb:beer
gptkb:water
gptkb:chloroform
lipids
|
gptkbp:IUPACName
|
1,3-bis(2-chloroethyl)-1-nitrosourea
|
gptkbp:KEGGID
|
D00297
|
gptkbp:legalStatus
|
prescription only
|
gptkbp:mechanismOfAction
|
alkylates DNA and RNA
|
gptkbp:meltingPoint
|
30-32°C
|
gptkbp:metabolism
|
liver
|
gptkbp:molecularWeight
|
214.05 g/mol
|
gptkbp:pregnancyCategory
|
D
|
gptkbp:PubChem_CID
|
2478
2578
CHEMBL1387
DB00262
|
gptkbp:routeOfAdministration
|
intravenous
implant (wafer)
|
gptkbp:sideEffect
|
nausea
vomiting
liver toxicity
pulmonary toxicity
bone marrow suppression
kidney toxicity
|
gptkbp:usedForTreatmentOf
|
leukemia
melanoma
multiple myeloma
Hodgkin lymphoma
brain tumors
|
gptkbp:WHOModelListOfEssentialMedicines
|
true
|
gptkbp:bfsParent
|
gptkb:BCNU
gptkb:Sigma-Tau_Pharmaceuticals
|
gptkbp:bfsLayer
|
8
|